STACEY KELLY: Open Payments
NPI 1881671634 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,997 in 100 payments from 24 companies in 2025. Trend: 2023 $8,743 · 2024 $4,700 · 2025 $2,997
Food & beverage: $2,997
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 10 | $393 |
| Novo Nordisk Inc | 13 | $361 |
| BETA BIONICS, INC. | 3 | $244 |
| Corcept Therapeutics | 10 | $240 |
| Lilly USA, LLC | 9 | $232 |
| Amgen Inc. | 7 | $222 |
| Abbott Laboratories | 11 | $210 |
| CeQur Corporation | 1 | $178 |
| Sequel Med Tech, LLC | 3 | $152 |
| Ascendis Pharma Endocrinology Inc | 2 | $140 |
Products named: Omnipod, iLet Bionic Pancreas, Korlym, Ozempic, FREESTYLE LIBRE 3, MOUNJARO, CeQur Simplicity, TWIIST.
Industry payments across FL — which companies pay providers there.
